Journal Logo

Articles by Daniel A. Hussar, PhD

New Drugs 2020, part 2

Hussar, Daniel A.

Nursing. 50(5):31-40, May 2020.

Review seven drugs recently approved by the FDA, including a new treatment for relapsing forms of multiple sclerosis and the second drug approved to treat female sexual dysfunction.

New Drugs 2020, part 1

Hussar, Daniel A.

Nursing. 50(2):31-38, February 2020.

This article reviews seven drugs recently approved by the FDA, including an adjunctive treatment for managing “off” episodes in patients with Parkinson disease.

New Drugs 2019, part 4

Hussar, Daniel A.

Nursing. 49(11):34-43, November 2019.

Learn about nine recently marketed drugs, including three new drugs for treating thrombocytopenia in select patients and the first drug that rapidly reverses the anticoagulant action of two factor Xa inhibitors, rivaroxaban and apixaban.

New Drugs 2019, part 3

Hussar, Daniel A.

Nursing. 49(8):24-32, August 2019.

This article reviews seven drugs recently approved by the FDA, including the first natural product derived from marijuana to receive FDA approval.

New Drugs 2019, part 2

Hussar, Daniel A.

Nursing. 49(5):32-41, May 2019.

This article reviews eight recently marketed drugs, including the first nonopioid approved to treat symptoms of opioid withdrawal and the first therapeutic angiotensin II product indicated to raise BP in adults with septic or other distributive shock.

New Drugs 2019, part 1

Hussar, Daniel A.

Nursing. 49(2):28-36, February 2019.

This article reviews seven drugs recently approved by the FDA, including two antidiabetic medications, a new combination medication for patients with cystic fibrosis, and the first gene therapy that targets a disease caused by mutations in a specific gene.

New Drugs 2018, part 3

Hussar, Daniel A.

Nursing. 48(10):32-43, October 2018.

Learn about select drugs recently approved by the FDA, including 3 new antibacterial drugs, 14 antineoplastic drugs, and 4 drugs indicated for rare disorders.

New Drugs 2018, Part 2

Hussar, Daniel A.

Nursing. 48(7):30-39, July 2018.

Delve into this review of nine drugs recently approved by the FDA, including two drugs to treat atopic dermatitis, two medications for patients with moderate-to-severe plaque psoriasis, and an important treatment advance for patients with primary progressive multiple sclerosis.

New Drugs 2018, part 1

Hussar, Daniel A.

Nursing. 48(2):36-44, February 2018.

Learn about seven drugs recently approved by the FDA, including two new combination formulations for hepatitis C virus infection, a drug for Clostridium difficile infection, and the second drug approved to treat amyotrophic lateral sclerosis.

New Drugs 2017, part 3

Hussar, Daniel A.

Nursing. 47(11):26-32, November 2017.

Learn about 11 drugs recently approved by the FDA, including a drug for Duchenne muscular dystrophy that received accelerated FDA approval, an important advance in the treatment of spinal muscular atrophy, and 5 new antineoplastic drugs.

NewDrugs 2017, part 2

Hussar, Daniel A.

Nursing. 47(7):28-36, July 2017.

Learn about seven drugs recently approved by the FDA, including two highly effective antiviral treatments for hepatitis C virus infection, a treatment for gout with a unique mechanism of action, and a fast-acting drug to reverse the muscle relaxant effects of vecuronium and rocuronium.

New Drugs 2017, part 1

Hussar, Daniel A.

Nursing. 47(2):32-39, February 2017.

Learn about six drugs recently approved by the FDA, including the first drug approved to treat hyperkalemia in 50 years, a breakthrough drug for Parkinson disease psychosis, and an I.V. antiasthmatic medication indicated for add-on maintenance treatment in certain patients with severe asthma.

New Drugs 2016, part 3

Hussar, Daniel A.

Nursing. 46(9):34-42, September 2016.

Learn about 23 drugs recently approved by the FDA, including one to treat irritable bowel syndrome characterized by diarrhea, an antiemetic to prevent delayed nausea and vomiting associated with cancer chemotherapy, and 14 new antineoplastic drugs.

New drugs 2016, part 2

Hussar, Daniel A.

Nursing. 46(7):26-33, July 2016.

Learn about seven drugs recently approved by the FDA, including the first medication approved for female sexual dysfunction, a specific reversal agent for dabigatran that neutralizes its anticoagulant activity, and two human monoclonal antibodies that are the first in a new class of lipid-lowering drugs.